Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
AU Stock MarketDetailed Quotes
Pharmaxis Ltd (PXS)
- 0.027
- 0.0000.00%
20min DelayMarket Closed Apr 12 10:00 AET
19.51MMarket Cap-1.59P/E (Static)
0.000High0.000Low0Volume0.000Open0.027Prev Close0.00Turnover0.00052wk High0.00%Turnover Ratio722.61MShares0.00052wk Low-0.017EPS TTM8.93MFloat Cap0.150Historical HighLossP/E (Static)330.70MShs Float0.026Historical Low-0.017EPS LYR0.00%Range %--Dividend TTM2.08P/B1Lot Size--Div Yield TTM
Pharmaxis Ltd (PXS) Income Statement
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | (FY)Jun 30, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -22.37%5.77M | 11.17%7.43M | -4.94%6.68M | 23.80%7.03M | -22.05%5.68M | -45.19%7.28M | -7.32%13.29M | -75.17%14.34M | 1,046.56%57.74M | 55.58%5.04M |
| Operating revenue | -22.37%5.77M | 11.17%7.43M | -4.94%6.68M | 23.80%7.03M | -22.05%5.68M | -45.19%7.28M | -7.32%13.29M | -75.17%14.34M | 1,046.56%57.74M | 55.58%5.04M |
| Cost of revenue | 2.71M | 62.84%1.86M | ||||||||
| Gross profit | -58.81%3.06M | 11.17%7.43M | -4.94%6.68M | 23.80%7.03M | -22.05%5.68M | -45.19%7.28M | -7.32%13.29M | -75.17%14.34M | 1,716.90%57.74M | 51.62%3.18M |
| Operating expense | -6.12%28.35M | 10.51%30.19M | -4.11%27.32M | -9.71%28.49M | -6.15%31.56M | -7.88%33.63M | -1.12%36.51M | -14.35%36.92M | -26.21%43.1M | 7.80%58.41M |
| Selling and administrative expenses | 6.67%15.83M | -9.19%14.84M | 3.35%16.34M | -4.92%15.81M | 2.12%16.63M | 6.99%16.28M | 1.41%15.22M | -28.47%15.01M | 17.94%20.98M | -10.71%17.79M |
| -Selling and marketing expense | -59.60%305K | -48.60%755K | 9.14%1.47M | 18.49%1.35M | -2.32%1.14M | 9.61%1.16M | -3.63%1.06M | -43.88%1.1M | -79.40%1.96M | -31.46%9.52M |
| -General and administrative expense | 10.23%15.52M | -5.30%14.08M | 2.81%14.87M | -6.64%14.47M | 2.47%15.49M | 6.79%15.12M | 1.80%14.16M | -26.88%13.91M | 130.04%19.02M | 37.11%8.27M |
| Research and development costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -25.82%17.7M |
| Depreciation amortization depletion | -42.93%1.85M | 2.73%3.24M | -2.60%3.15M | 23.56%3.24M | -21.82%2.62M | 9.51%3.35M | 1.02%3.06M | -16.93%3.03M | -74.25%3.65M | 193.63%14.15M |
| -Depreciation and amortization | -42.93%1.85M | 2.73%3.24M | -2.60%3.15M | 23.56%3.24M | -21.82%2.62M | 9.51%3.35M | 1.02%3.06M | -16.93%3.03M | -74.25%3.65M | 193.63%14.15M |
| Provision for doubtful accounts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---54K | ---- |
| Other operating expenses | -11.94%10.67M | 54.76%12.12M | -17.12%7.83M | -23.27%9.45M | -12.03%12.31M | -23.21%14M | -3.47%18.23M | 1.89%18.88M | 111.40%18.53M | 57.07%8.77M |
| Operating profit | -11.07%-25.29M | -10.30%-22.77M | 3.84%-20.64M | 17.06%-21.47M | 1.76%-25.88M | -13.47%-26.35M | -2.82%-23.22M | -254.29%-22.58M | 126.50%14.64M | -6.03%-55.23M |
| Net non-operating interest income (expenses) | -100.78%-106K | 4,367.08%13.61M | -112.64%-319K | 276.15%2.52M | 1,817.14%671K | -56.25%35K | -97.82%80K | 7.46%3.67M | 161.38%3.42M | -2,126.80%-5.57M |
| Non-operating interest income | -25.00%117K | 212.00%156K | -98.02%50K | 177.67%2.52M | 52.01%909K | -14.94%598K | -42.04%703K | 68.24%1.21M | -58.44%721K | -35.62%1.74M |
| Non-operating interest expense | 101.66%223K | -3,746.61%-13.46M | --369K | ---- | -57.73%238K | -9.63%563K | 125.34%623K | 8.79%-2.46M | -136.92%-2.7M | 147.95%7.3M |
| Other net income (expenses) | 94.38%14.03M | -59.87%7.22M | 259.82%17.99M | -3.01%5M | -84.17%5.16M | 579.55%32.57M | 95.23%4.79M | 440.75%2.46M | 108.96%454K | -227.18%-5.07M |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 47.43%-174K | 96.23%-331K | -419.70%-8.78M |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 419.70%8.78M |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -47.43%174K | --331K | ---- |
| Other non-operating income (expenses) | 94.38%14.03M | -59.87%7.22M | 259.82%17.99M | -3.01%5M | -84.17%5.16M | 579.55%32.57M | 82.31%4.79M | 234.90%2.63M | -78.87%785K | -34.54%3.72M |
| Income before tax | -486.78%-11.36M | 34.81%-1.94M | 78.70%-2.97M | 30.49%-13.94M | -412.43%-20.06M | 134.99%6.42M | -11.49%-18.35M | -188.91%-16.46M | 135.79%18.51M | -18.79%-51.72M |
| Income tax | 0 | 0 | 0 | 0 | 0 | -8K | 0 | -83.33%7K | -59.22%42K | 5,050.00%103K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -486.78%-11.36M | 34.81%-1.94M | 78.70%-2.97M | 30.49%-13.94M | -412.04%-20.06M | 135.04%6.43M | -11.44%-18.35M | -189.15%-16.46M | 135.64%18.47M | -19.02%-51.82M |
| Net income continuous operations | -486.78%-11.36M | 34.81%-1.94M | 78.70%-2.97M | 30.49%-13.94M | -412.04%-20.06M | 135.04%6.43M | -11.44%-18.35M | -189.15%-16.46M | 135.64%18.47M | -19.02%-51.82M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -486.78%-11.36M | 34.81%-1.94M | 78.70%-2.97M | 30.49%-13.94M | -412.04%-20.06M | 135.04%6.43M | -11.44%-18.35M | -189.15%-16.46M | 135.64%18.47M | -19.02%-51.82M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -486.78%-11.36M | 34.81%-1.94M | 78.70%-2.97M | 30.49%-13.94M | -412.04%-20.06M | 135.04%6.43M | -11.44%-18.35M | -189.15%-16.46M | 135.64%18.47M | -19.02%-51.82M |
| Diluted earnings per share | -408.82%-0.0173 | 51.43%-0.0034 | 80.00%-0.007 | 33.46%-0.035 | -363.00%-0.0526 | 134.48%0.02 | -11.54%-0.058 | -188.14%-0.052 | 135.12%0.059 | -19.15%-0.168 |
| Basic earnings per share | -408.82%-0.0173 | 51.43%-0.0034 | 80.00%-0.007 | 33.46%-0.035 | -363.00%-0.0526 | 134.48%0.02 | -11.54%-0.058 | -188.14%-0.052 | 135.12%0.059 | -19.15%-0.168 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"